Dongze Liu

768 total citations
36 papers, 578 citations indexed

About

Dongze Liu is a scholar working on Pharmacology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dongze Liu has authored 36 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 12 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dongze Liu's work include Fungal Biology and Applications (12 papers), Microbial Natural Products and Biosynthesis (7 papers) and Ferroptosis and cancer prognosis (7 papers). Dongze Liu is often cited by papers focused on Fungal Biology and Applications (12 papers), Microbial Natural Products and Biosynthesis (7 papers) and Ferroptosis and cancer prognosis (7 papers). Dongze Liu collaborates with scholars based in China, Germany and Taiwan. Dongze Liu's co-authors include Ji‐Kai Liu, Fei Wang, Jian‐Guo Tang, Hua‐Jie Zhu, Wölfgang Steglich, Fei Wang, Ze‐Jun Dong, Xiaofang Wang, Yong Xu and Guangyu Sun and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Organic Letters.

In The Last Decade

Dongze Liu

34 papers receiving 568 citations

Peers

Dongze Liu

PHARM

Young Taek Han South Korea

Neetu Agrawal India

Yanlong Yang China

Xixin He China

N. Bhagya India

Jing‐Xu Gong China

Fenghua Kang China

François Gaascht Luxembourg

Ting Lin China

Zheling Feng China

Young Taek Han South Korea

Dongze Liu

104 ×0.4

PHARM

232 ×1.0

315 ×2.2

38 ×0.5

36 ×0.5

Citations per year, relative to Dongze Liu Dongze Liu (= 1×) peers Young Taek Han

Countries citing papers authored by Dongze Liu

Since Specialization

Citations

This map shows the geographic impact of Dongze Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongze Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongze Liu more than expected).

Fields of papers citing papers by Dongze Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongze Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongze Liu. The network helps show where Dongze Liu may publish in the future.

Co-authorship network of co-authors of Dongze Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Dongze Liu. A scholar is included among the top collaborators of Dongze Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongze Liu. Dongze Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Bo, Weiyang Liu, Wan‐Hui Wang, et al.. (2025). CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis. Frontiers in Immunology. 16. 1619361–1619361.

Liu, Dongze, et al.. (2024). Comprehensive analysis of disulfidptosis-related genes: a prognosis model construction and tumor microenvironment characterization in clear cell renal cell carcinoma. Aging. 16(4). 3647–3673. 1 indexed citations

Liu, Dongze, et al.. (2024). Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer. Cancer Cell International. 24(1). 294–294. 2 indexed citations

Liu, Dongze, et al.. (2024). Inflammatory cytokine profiles in erectile dysfunction: a bidirectional Mendelian randomization. Frontiers in Immunology. 15. 1342658–1342658. 7 indexed citations

Liu, Dongze, Qin Zheng, Hongbo Xie, et al.. (2023). Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer. Aging. 15(24). 15134–15160. 5 indexed citations

Zheng, Qin, Dongze Liu, Xiaoxu Chen, et al.. (2023). Inhibitory function of CDK12i combined with WEE1i on castration-resistant prostate cancer cells in vitro and in vivo. ONCOLOGIE. 25(6). 717–728. 1 indexed citations

Liu, Dongze, et al.. (2023). Anoikis-related gene signature as novel prognostic biomarker to predict immunotherapy with bladder urothelial carcinoma. ONCOLOGIE. 25(3). 291–308. 2 indexed citations

Zhang, Man, et al.. (2023). Pan-cancer analysis reveals the prognostic and immunotherapeutic value of cytoskeleton-associated protein 2-like. Scientific Reports. 13(1). 8368–8368. 4 indexed citations

Liu, Dongze, Qin Zheng, Liang Zhu, et al.. (2023). CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy. Frontiers in Oncology. 13. 1170397–1170397. 5 indexed citations

10.

Wang, Kaibin, et al.. (2022). Pan-cancer analysis of the prognostic and immunological role of PAQR4. Scientific Reports. 12(1). 21268–21268. 2 indexed citations

11.

Liu, Dongze, et al.. (2022). Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma. Frontiers in Genetics. 13. 938259–938259. 72 indexed citations

12.

Liu, Dongze, et al.. (2022). Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs. Frontiers in Immunology. 13. 916800–916800. 10 indexed citations

13.

Wang, Xiaofang, et al.. (2017). A composite formation strategy for multiple missiles. 684–691. 5 indexed citations

14.

Liu, Qi, Weiya Zhang, Hongyu Wang, et al.. (2016). Validation of a HILIC Method for the Analysis of Ergothioneine in Fermentation Broth. Journal of Chromatographic Science. 54(6). 934–938. 10 indexed citations

15.

Liu, Dongze, et al.. (2015). Two New Pyrrolosesquiterpenes Produced by a Streptomyces Species. Chemistry & Biodiversity. 12(1). 153–156. 6 indexed citations

16.

Liu, Dongze, et al.. (2014). New Triterpenoids from the Fruiting Bodies of Ganoderma lucidum and Their Bioactivities. Chemistry & Biodiversity. 11(6). 982–986. 22 indexed citations

17.

Liu, Dongze, et al.. (2014). New bicyclic hemiacetals from the edible mushroom Ramaria madagascariensis. The Journal of Antibiotics. 68(2). 137–138. 5 indexed citations

18.

Liu, Dongze, et al.. (2014). A new pyrrolosesquiterpene isolated from cultures of Streptomyces sp.. The Journal of Antibiotics. 67(5). 415–417. 6 indexed citations

19.

Liu, Dongze, Qi Liu, Ping Yang, & Wenxia Jiang. (2014). A New Ergostane Triterpenoid from Cultures of the Basidiomycete Inocybe lilacina. Natural Product Communications. 9(3). 369–70. 1 indexed citations

20.

Liu, Dongze, et al.. (2010). Two new chamigrane metabolites from fermentation broth of Steccherinum ochraceum. Fitoterapia. 81(8). 1205–1207. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact